Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227.
about
Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL).High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group.Impact of treatment variability on survival in immuno-competent and immuno-compromised patients with primary central nervous lymphoma.The Elderly Left Behind - Changes in Survival Trends of Primary Central Nervous System Lymphoma Over The Past Four Decades.Diagnosis and management of primary central nervous system lymphoma.Primary CNS Lymphoma.Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients.The Diagnosis and Treatment of Primary CNS LymphomaResponse-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy
P2860
Q39279101-6E16EF06-8603-48DC-97C3-0BF1AB2155A9Q40179899-C6F6FA1B-D9A1-4551-AAB5-7113166247C0Q40330547-88D03336-760C-49B6-A048-666C7E6CC0C9Q48016610-28C5B229-C286-4639-A5D1-E33AA4A05A2AQ48095976-AF4C2826-B9BD-41CF-8D8E-5E6931470266Q51841565-F0375271-76B4-4B10-89F8-2AAA825336E5Q55688305-F414A48F-6482-47EC-BED6-ED39B95B5EAEQ56967801-01819104-BBBB-4838-8EE3-A796DDDB408CQ58130542-104E70CC-1C77-4F4A-97D6-956C1FF6DD6F
P2860
Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Phase I and II Study of Induct ...... phoma: NRG Oncology RTOG 0227.
@ast
Phase I and II Study of Induct ...... phoma: NRG Oncology RTOG 0227.
@en
type
label
Phase I and II Study of Induct ...... phoma: NRG Oncology RTOG 0227.
@ast
Phase I and II Study of Induct ...... phoma: NRG Oncology RTOG 0227.
@en
prefLabel
Phase I and II Study of Induct ...... phoma: NRG Oncology RTOG 0227.
@ast
Phase I and II Study of Induct ...... phoma: NRG Oncology RTOG 0227.
@en
P2093
P2860
P356
P1476
Phase I and II Study of Induct ...... phoma: NRG Oncology RTOG 0227.
@en
P2093
Barbara Jean Fisher
Christopher J Schultz
Daniel Brat
Felix Bokstein
John H Suh
Joseph A Bovi
Marcia K Liepman
Mark Augspurger
Matthew C Solhjem
P2860
P304
P356
10.1200/JCO.2015.64.8634
P407
P577
2016-03-28T00:00:00Z